DJIA 17,776.91 93.33 0.53%
NASDAQ 4,997.46 5.52 0.11%
S&P 500 2,081.34 12.58 0.61%
market minute promo

Geron Corp (NASDAQ: GERN)

4.19 -0.13 (-3.01%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GERN $4.19 -3.01%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.32
Previous Close $4.32
Daily Range $4.13 - $4.32
52-Week Range $1.76 - $4.67
Market Cap $662.4M
P/E Ratio -18.78
Dividend (Yield) $0.00 (0.0%)
Volume 2,592,113
Average Daily Volume 2,433,282
Current FY EPS -$0.07




Drug Makers

Geron Corp (GERN) Description

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS. Website:

News & Commentary Rss Feed

3 Experimental Cancer Drugs Investors Should Be Closely Watching

Meet the drugs our experts believe have shown the most promising results in the race to cure cancer.

Geron (GERN) Is Today's Dead Cat Bounce Stock

Geron (GERN) Highlighted As Weak On High Volume

Premarket Biotech Digest: Geron's Sharp Gain, Bayer Essure AEs, Juno Moves Higher

This Biotech Stock Has Jaw-Dropping Growth Potential

Geron Corp. is small-cap biotech with major growth potential.

Geron Is Ripe For A Short Squeeze

Can the Rally in Geron (GERN) Shares Continue? - Tale of the Tape

Strong On High Relative Volume: Geron (GERN)

The Best Pairs Trade In The Market: Buy Geron And Short Incyte

Geron (GERN) Strong On High Relative Volume Today

See More GERN News...

GERN's Top Competitors

GERN $4.19 (-3.01%)
Current stock: GERN
CELG $119.28 (0.39%)
Current stock: CELG
AMGN $155.39 (0.58%)
Current stock: AMGN
BIIB $408.06 (0.85%)
Current stock: BIIB